Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Michael Cole-Fontayn
Chief Executive Officer,
Depositary Receipts Division
The increase in DR trading value and volume can be traced to the upsurge in U.S.
investment in non-U.S. equities. In the first six months of 2010, the total value of
U.S. investment in non-U.S. equities (both DRs and non-U.S. shares) increased a
remarkable 68% to about $4.2 trillion. Non-U.S. equities accounted for 19.8% of all
equity investment in the U.S., an increase from 18.4% at the same time last year.
Emerging markets dominated the depositary receipt scene in the first half of
2010, especially the BRIC countriesBrazil, Russia, India and China. India and
China led new DR program establishment and DR capital raisings, and the two
most actively traded DR programsVale and Petrobraswere both from Brazil.
During the first six months of 2010, BNY Mellon grew its depositary leadership
position across many metrics, acting for 59% of all new sponsored DR programs
and 83% of all DR capital-raising transactions. BNY Mellon acts as depositary for
63% of all sponsored DR programs globally.
As a global strategic advisor, BNY Mellon distinguished itself by supporting major
international corporate events for companies such as VimpelCom, Rusal, and
Telmex Internacional, all of which are described in greater detail on pages 10-11.
In June, BNY Mellon demonstrated its strategic focus on innovation in the
financial markets by acting as structural advisor to the U.K. bank Standard
Chartered when it became the first company to list an Indian depositary receipt
program in India and the first non-Indian company to sell shares (in the form of
Indian depositary receipts) directly to Indian investors.
We look forward to continuing our tradition of growth and innovation in 2010 and
to supporting our clients by further integrating the worlds markets.
Michael Cole-Fontayn
1
Table of Contents
Depositary Receipt Market Highlights
During the first six months of 2010, $1.84 trillion of DRs traded on
U.S. and non-U.S. markets and exchanges, a record high and a 41.5%
increase year-over-year.
Depositary Receipt Trading
The total value of U.S. investment in non-U.S. equities (both DRs and
non-U.S. shares) increased 68% to about $4.2 trillion. At the same
the U.S., an increase from 18.4% at the same time last year.
6
7
10
12
issuers from nine countries completed 44 new primary and followon DR offerings, raising nearly $4.1 billion. India and China together
accounted for 34 of the offerings and about half the total value raised.
The BNY Mellon ADR Index is a service mark owned by The Bank of New York Mellon Corporation.
first half of 2010, one issuer, the U.K.s Britvic, chose to list its
five from Russia and four each from Australia, Brazil, Japan and
By Type
By Country, 1H 10
200
150
18
100
India
50
China
32
0
'01
'02
'03
'04
U.S.-Listed
'05
'06
'07
OTC-Traded
'08
09
Russia
1H 10*
9
GDR
Others
followed by Japan with 272 and the U.K. with 239. China came
close behind with 232, with Russias 219 completing the top
By Type
By Country, 1H 10
3,500
3,000
2,500
2,000
1,500
1,000
500
0
302
272
239
1,987
'01
'02
'03
'04
U.S.-Listed
'05
'06
'07
OTC-Traded
'08
09
GDR
234
1H 10*
190
India
Japan
UK
China
Russia
Others
$1.7
$36.4
$152.4
NYSE
$312.6
NASDAQ
OTC
LSE/LuxSE
$1,342.6
NYSE Amex
4.0
3.5
Value ($tr)
120
100
3.0
2.5
2.0
1.5
1.0
80
60
40
20
.5
0
0
'01
'02
'03
'04
'05
'06
'07
'08
Company
Country
Value
(bb)
Volume
(mm)
BP
U.K.
$149.5
3,810.0
Baidu
China
$125.2
689.7
Vale - Common
Brazil
$104.7
3,746.4
Brazil
$82.5
2,019.5
Teva Pharmaceutical
Israel
$48.0
831.4
Nokia
Finland
$45.0
3,705.4
BHP Billiton
Australia
$43.4
605.9
Vale - Preferred
Brazil
$34.4
1,439.9
Brazil
$33.3
1,669.2
Brazil
$30.6
851.2
Source: BNY Mellon and various stock exchanges. All figures as of June 30, 2010.
'09 1H 10*
By Country, 1H 10 (bb)
$443.8
$507.1
Brazil
UK
China
Mexico
$331.2
$49.5
$65.7
$259.6
Israel
Others
Volume (bb)
in the first six months of 2010, 13.1% higher and 56.2% higher,
representing an 11% increase from last years 1.8 billion at the mid-
Company
Gazprom
Country
Value
(bb)
Volume
(mm)
Russia
$45.5
Company
Country
Value
(mm)
Volume
(mm)
1,976.5
Nestl
Switzerland
$3,740.8
77.7
46.2
LUKOIL
Russia
$26.1
475.6
Roche
Switzerland
$1,830.0
Rosneft
Russia
$19.1
2,441.3
Nintendo
Japan
$1,353.7
36.3
Russia
$13.4
809.2
Gazprom
Russia
$985.1
43.2
Russia
$7.4
215.0
Anglo American
U.K.
$849.3
42.6
Russia
$5.2
73.0
LUKOIL
Russia
$803.5
14.7
Russia
$3.8
753.2
BASF
Germany
$767.8
13.2
South Korea
$3.1
9.5
Allianz
Germany
$730.9
66.2
Russia
$3.0
236.2
E.ON
Germany
$645.7
19.3
Russia
$3.0
143.8
Bayer
Germany
$634.4
10.1
Norilsk Nickel
Evraz
Novatek
VTB
Samsung Electronics
Severstal
Uralkali
IOB-Traded, 1H 10
OTC-Traded, 1H 10
600
15
120
80
40
300
200
Volume (bb)
10
Value ($bb)
400
Volume (bb)
Value ($bb)
500
100
0
0
'01
'02
'03
'04
'05
'06
'07
'08
'09 1H 10*
'01
'02
'03
'04
'05
'06
'07
'08
'09 1H 10*
By Country, 1H 10 (bb)
By Country, 1H 10 (bb)
$6.1
Russia
Luxembourg
Switzerland
UK
$15.0
Egypt
$5.5
France
India
South Korea
$132.4
Germany
Russia
$4.2
Others
$2.4
Others
$3.2
Source: BNY Mellon and various stock exchanges. All figures as of June 30, 2010.
countries raised nearly $2.4 billion, more than 50% of the global
By Exchange, 1H 10 (bb)
GDRs
ADRs
60
50
40
$1.4
$1.5
NYSE
30
NASDAQ
20
Luxembourg
10
Other
$0.5
0
'01
'02
'03
'04
'05
'06
'07
'08
'09
1H 10*
$0.7
* Note: 2010 represents half-year figures.
Offering
DRs
DR Value
Company
Country
DR Exchange
Date
Price
(mm)
(mm)
Gafisa
Brazil
NYSE
March 25
$14.0
37.0
$519.1
Alliance Bank
Kazakhstan
None
March 19
$11.3
31.2
$352.1
Essar Oil
India
None
April 27
$483.3
0.6
$293.3
Mechel Steel
Russia
NYSE
May 12
$7.5
33.5
$251.1
CTrip.com
China
NASDAQ
March 9
$36
6.6
$236.0
Essar Oil
India
None
May 28
$482.9
0.5
$225.0
AvangardCo Investments
Ukraine
LSE
May 5
$15.0
14.4
$215.6
Trina Solar
China
NYSE
March 19
$20.3
9.1
$184.0
Rusal
Russia
NYSE Euronext-Paris
January 25
$28.1
6.3
$177.4
Mindray Medical
China
NYSE
March 9
$38.2
4.6
$175.7
Source: BNY Mellon and various stock exchanges. All figures as of June 30, 2010.
30
25
20
15
2
10
0
'01
'02
'03
'04
'05
'06
'07
'08
'09
200
% of Portfolio
Value ($tn)
1Q '10
150
100
50
0
'01
'02
'03
'04
'05
'06
'07
'08
'09
1Q 10
Source: U.S. Federal Reserve as of June 10, 2010. Historical figures revised by U.S. Federal Reserve as of June 10, 2010.
billion, with DRs accounting for 5.7% of total equity in its global
1H 10 DR
1H 09 DR
Total Equity
Investment
Value (mm)
Value (mm)
Assets (mm)
Style
Equity Portfolio
DR Value as a
Turnover (%)
% of Total Equity
$30,369
$18,930
$528,996
Growth
38
5.7
$21,306
$15,608
$750,794
$20,010
$13,265
$108,817
Index
19
2.8
Deep Value
17
18.4
$18,853
$11,484
$385,585
GARP
27
4.9
$16,710
$12,368
$266,515
Value
46
6.3
$15,644
$13,498
$377,625
Value
28
4.1
$12,316
$7,950
$33,259
GARP
11
37.0
$12,301
$7,402
$206,556
Growth
53
6.0
$10,703
$8,403
$264,812
Growth
30
4.0
$8,845
$6,312
$54,342
Value
45
16.3
Investor
Fidelity Management & Research
By Market, 1H 10 (bb)
By Region, 1H 10 (bb)
$114.1
$175.8
$341.5
$220.0
Asia-Pacific
U.S.-Listed
EEMEA
European-Listed
OTC-Traded/Other
$763.0
$345.7
Latin America
Western Europe
$234.1
U.K.
Teva Pharmaceutical
Israel
Gazprom
Russia
LUKOIL
Russia
Brazil
Mexico
Brazil
Vale Common
Brazil
U.K.
Vodafone Group
U.K.
Value of Outstanding
DRs (bb)*
Mkt. Cap.
(bb)
% of Total
Mkt. Cap.
NYSE
$49.8
$121.8
40.9
NASDAQ
$45.6
$52.1
87.5
$33.8
$123.7
27.3
$32.6
$45.2
72.1
NYSE
$29.0
$146.7
19.8
NYSE
Mobile Telecom.
$28.6
$100.4
28.5
NYSE
$25.8
$146.7
17.6
NYSE
$23.3
$126.8
18.4
NYSE
$20.1
$168.0
12.0
NASDAQ
Mobile Telecom.
$16.8
$119.0
14.1
Source: BNY Mellon, other depositaries and various stock exchange. All data as of June 30, 2010.
*Research methodology: Value of outstanding DRs was derived by multiplying DRs outstanding by DR price. All DR price figures are publicly available from the applicable stock exchanges
or trading markets. The number of DRs outstanding for issues sponsored by BNY Mellon was derived from internal reporting sources. The number of DRs outstanding for non-BNY Mellonsponsored U.S.-listed issues was derived from publicly available figures provided by the NYSE and NASDAQ. DRs outstanding from European-listed and OTC-traded issues that are not BNY
Mellon-sponsored were estimated using publicly available information including, but not limited to, company reports and SEC 13-F shareholder data.
YTD
% Change
544.5
26.3
101.4
19.9
214.6
15.3
391.6
14.9
1060.6
2.6
while the India Select DR Index and New Frontier DR Index led
gainers with returns of 3.60% and 1.81%, respectively, year-
YTD
% Change
Baidu
China
65.6
Japan
60.8
Trintech Group
Ireland
52.6
Taiwan
51.6
Spreadtrum Communications
China
50.9
Trinity Biotech
Ireland
50.5
ARM Holdings
U.K.
44.9
China
34.2
ICON
Ireland
32.9
CNinsure
China
29.2
20%
15%
YTD
% Change
10%
5%
274.2
-5.7
0%
113.7
-10.9
-5%
-10%
279.8
-11.2
332.9
-15.6
-15%
113.0
-17.1
-20%
79.6
-18.8
-25%
-30%
'06J A
300.19
-9.66
MSCI EAFE
1348.11
-14.72
212.76
-12.41
MSCI AC Europe
327.81
-18.08
MSCI AC Asia-Pacific
MSCI EM Latin America
MSCI Emerging Markets
O '07J A
O '08J A
O '09J A
O '10J A
YTD
% Change
112.80
-6.36
3639.55
-11.59
917.99
-7.22
1030.71
-7.57
9774.02
-6.27
As the only real-time index to track all DRs, New York Shares and global registered shares traded on the NYSE, NYSE Amex and NASDAQ, The BNY Mellon ADR Index has become a
widely followed international benchmark.
Raw data for the BNY Mellon ADR Index is provided by Dow Jones & Company, Inc
Source: BNY Mellon and Bloomberg. Data as of June 30, 2010.
on the Hong Kong Stock Exchange and its GDRs on the NYSE
Number of DR Programs
Euronext-Paris.
2,500
2,000
1,500
1,000
500
0
'01
'02
BNY Mellon
'03
'04
'05
JPMorgan Chase
'06
'07
Citibank
'08
09
1H 10*
Deutsche Bank
10
11
Asia-Pacific
Beijing
Kathy Jiang, VP
Phone: +86 10 8800 7555
kathy.jiang@bnymellon.com
New York
Nuno da Silva, MD
Latin America
Phone: +1 212 815 2233
nuno.da.silva@bnymellon.com
Hong Kong
Gregory Roath, MD
Asia-Pacific
Phone: +852 2840 9821
gregory.roath@bnymellon.com
Marianne Erlandsen, MD
Western Europe
Phone: +1 212 815 4747
marianne.erlandsen@bnymellon.com
Emerging Europe,
Middle East and Africa
Western Europe
Beirut
Bana Akkad Azhari, VP
Phone: +961 1 988 788
bana.akkad@bnymellon.com
London
James Green, MD
Secondary Market Solutions
Phone: +44 207 964 6080
james.t.green@bnymellon.com
Cairo
Tarek El-Refai, MD
Phone: +202 333 65818
tarek.elrefai@bnymellon.com
Frankfurt
Rainer Wunderlin, MD
Phone: +49 69 9715 1226
rainer.wunderlin@bnymellon.com
Melbourne
Gary Peck, MD
Phone: +61 3 9640 3916
gary.peck@bnymellon.com
Dubai
Peter Gotke, VP
Phone: +971 4425 2542
peter.gotke@bnymellon.com
Milan
Adriana Pierelli, VP
Phone: +39-02 879 0923
adriana.pierelli@bnymellon.com
Michael Finck, MD
Transactions and Corporate Actions
Phone: +1 212 815 2190
michael.finck@bnymellon.com
Mumbai
Aparna Salunke, VP
Phone: +91 22 3028 2312
aparna.salunke@bnymellon.com
Istanbul
Michel Sidier, MD
Phone: +90 212 259 0466
michel.sidier@bnymellon.com
Paris
Benjamin Brisedou, VP
Phone: +33 1 4297 9022
benjamin.brisedou@bnymellon.com
Chris Kearns, MD
Product Management
Phone: +1 212 298 1240
christopher.kearns@bnymellon.com
Seoul
Sean Lim, VP
Phone: +82 2 399 0040
sukkyu.lim@bnymellon.com
Moscow
Irina Baichorova, VP
Phone: +7 495 967 3110
irina.baichorova@bnymellon.com
Anthony Moro, MD
Emerging Europe and Africa
Phone: +1 212 815 5838
anthony.moro@bnymellon.com
Shanghai
Caleb Shih, VP
Phone: +86 21 5888 2919
caleb.shih@bnymellon.com
Latin America
Mahmoud Salem, MD
Middle East
Phone: +1 212 815 2248
mahmoud.salem@bnymellon.com
Taipei
Frances Ni, VP
Phone: +886 2 2711 0995
frances.ni@bnymellon.com
Dave Stueber, MD
Global Business Development
Phone: +1 212 815 2981
david.stueber@bnymellon.com
12
Tokyo
Kainoshin Hara, MD
Phone: +81 3 3595 1071
kainoshin.hara@bnymellon.com
Buenos Aires
Ciro Ortiz, VP
Phone: +54 11 4345 9990
ciro.ortiz@bnymellon.com
Mexico City
Paulina Trueba, VP
Phone: +52 55 3544 0237
paulina.trueba@bnymellon.com
So Paulo
Curtis Smith, VP
Phone: +55 11 3050 8306
curtis.smith@bnymellon.com
13
BNY Mellon is the corporate brand of BNY Mellon Corporation and may also be used as a generic term to reference the corporation as a whole or its various subsidiaries.
BNY Mellon is a global financial services company focused on helping clients manage and service their financial assets, operating in 34 countries and serving more than
100 markets. BNY Mellon is a leading provider of financial services for institutions, corporations and high-net-worth individuals, providing superior asset management
and wealth management, asset servicing, issuer services, clearing services and treasury services through a worldwide client-focused team. It has $22.4 trillion in assets
under custody and administration, $1.1 trillion in assets under management, services $12 trillion in outstanding debt, and processes global payments averaging $1.5 trillion
per day. Additional information is available at bnymellon.com.
This information and data are provided for general informational purposes only. BNY Mellon does not warrant or guarantee the accuracy or completeness of, nor
undertake to update or amend, this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. Nothing
herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Members FDIC. 2010 BNY Mellon Corporation. Services provided by BNY Mellon and its various subsidiaries. All rights reserved.
Depositary Receipts:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED. MAY LOSE VALUE.
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE.